DC Vaccination
DC vaccination, or dendritic cell vaccination, involves using dendritic cells to stimulate the immune system to target specific antigens, often used in cancer immunotherapy. This approach leverages the body's natural immune response to enhance the detection and destruction of cancer cells, potentially contributing to longevity by improving cancer treatment outcomes.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.